Assessing the Therapeutic Role of Oral Gastrografin in Subacute Intestinal Obstruction
DOI:
https://doi.org/10.51253/pafmj.v74i6.6179Keywords:
Conservative Treatment, Gastrografin, Intestinal obstruction, Length Of Stay, Patient ReadmissionAbstract
Objective: To assess the therapeutic role of gastrografin in patients with subacute intestinal obstruction.
Study Design: Quasi-experimental study.
Place and Duration of Study: Surgical Department, Combined Military Hospital, Rawalpindi, Pakistan from Jul to Dec 2019.
Methodology: A total of 112 patients who presented to Combined Military Hospital, Rawalpindi with subacute intestinal obstruction were included. Fifty-six patients were each allotted into group-A and group-B. Group-A were controls and received conventional treatment, whereas group-B, which was the study group received addition of 100 ml gastrografin meal. Patients were followed up with variables like operative rates, hospital stay during the admission and further readmissions with similar complaints were also assessed in next 3months time.
Results: Surgical operation was performed in 14(25%) of the non-gastrografin group (group-A), for whom conservative treatment failed. In contrast, surgery was required in 5(8.9%) patients from the gastrografin group (group-B). The length of hospital stay showed a significant reduction from 5.02±1.61 days to 3.2±0.72 days for groups A and B, respectively. Readmission rate between groups was not statistically significant (p=0.151).
Conclusion: We concluded that the gastrografin administration in subacute intestinal obstruction has a definite advantage in terms of lower surgery rate and reduced hospital stay.
Downloads
References
Kumar A, Prasad R, Jakhar DS, Jajra D, Chhabra SK, Rai A, et al. Prospective analysis of the management of small bowel obstruction using oral contrast agent at tertiary care hospital in western Rajasthan. Int Surg J 2018; 5(4): 1403-1406.
https://doi.org/10.18203/2349-2902.isj20181119
Alsimail MW, Alnaim AA, Alramadhan FS, Sagga BK, Alnomari LF, Almeashi NA, et al. Role of Gastrografin Challenge in Diagnosis of Small Intestinal Obstruction. Arch Pharma Pract 2019; 10(4): 21-24.
Safamanesh S, Pazouki A, Tamannaie Z, Mohammadalipour B, Ramezani K, Hajnasrollah E, et al. Evaluation of Gastrografin TherapeuticRole on the Management of Small Bowel Obstruction. J Minim Invasive Surg Sci 2012; 1(3): 90-93.
https://doi.org/10.5812/jmiss.6996
Farid M, Fikry A, El Nakeeb A, Fouda E, Elmetwally T, Yousef M, et al. Clinical impacts of oral Gastrografin follow-through in adhesive small bowel obstruction (SBO). J Surg Res 2010; 162(2): 170-176.
https://doi.org/10.1016/j.jss.2009.03.092
Ceresoli M, Coccolini F, Catena F, Montori G, Di Saverio S, Sartelli M, et al. Water-soluble contrast agent in adhesive small bowel obstruction: a systematic review and meta-analysis of diagnostic and therapeutic value. Am J Surg 2016; 211(6): 1114-1125.
https://doi.org/10.1016/j.amjsurg.2015.06.012
Almafreji I, Chinaka U, Hussain A, Lynch M, Cottrell R. Role of Gastrografin in Patients with Small Bowel Obstruction. Cureus 2020; 12(8): e9695.
https://doi.org/10.7759/cureus.9695
Shahid MA, Bhatta P, Raya A, Rai BK. Therapeutic Role of Gastrograffin in Adhesive Small Bowel Obstruction After Unsuccessful Conservative Treatment. Med Phoenix 2020; 5(1): 26-31.
https://doi.org/10.3126/medphoenix.v5i1.31395
Nelms DW, Kann BR. Imaging modalities for evaluation of intestinal obstruction. Clin Colon Rectal Surg 2021; 34(04): 205-218.
https://doi.org/10.1055/s-0041-1729737
Alnachoukati O, Ray-Zack M, Godin S, Apodaca T, Zielinski M, Dunn J. Optimal Timing of First Abdominal Radiography after Gastrografin Administration for Small Bowel Obstruction. J Surg Res 2020; 256: 193-197.
https://doi.org/10.1016/j.jss.2020.06.053
Mansoori B, Vasan V, Xi Y, Fielding JR. Variations in use of “water soluble contrast challenge” for small bowel obstruction among academic radiologists: results of a national survey. Abdom Radiol 2020; 45(2): 1050-1056.
https://doi.org/10.1007/s00261-020-02436-3
Singla RL, Singh B, Kumar A, Kumar P, Khandelwal A. Role of Gastrografin Contrast Study in Intestinal Obstruction. Int J Anat Radiol Surg 2017; 6(3): SO01-SO05.
Bueno-Lledó J, Barber S, Vaqué J, Frasson M, Garcia-Granero E, Juan-Burgueño M, et al. Adhesive small bowel obstruction: predictive factors of lack of response in conservative management with Gastrografin. Dig Surg 2016; 33(1): 26-32.
https://doi.org/10.1159/000441530
Pujahari AK. Decision making in bowel obstruction: a review. J Clin Diagn Res: JCDR 2016; 10(11): PE07-PE12.
https://doi.org/10.7860/JCDR/2016/22170.8923
Rajkumar PN, Nagaraj B, Bharathi H, Yogish B. To study the efficacy of Gastrografin in diagnosis of adhesive small bowel obstruction Indian J Public Health Res Dev 2014; 5(1): 158-162.
https://doi.org/10.5958/j.0976-5506.5.1.036
Isaksson K, Weber E, Andersson R, Tingstedt B. Small bowel obstruction: early parameters predicting the need for surgical intervention. Eur J Trauma Emerg Surg 2011; 37(2): 155-159.
https://doi.org/10.1007/s00068-010-0033-x
Koh A, Adiamah A, Chowdhury A, Mohiuddin MK, Bharathan B. Therapeutic Role of Water-Soluble Contrast Media in Adhesive Small Bowel Obstruction: a Systematic Review and Meta-Analysis. J. Gastrointest Surg 2020; 24(2): 473-483.
https://doi.org/10.1007/s11605-019-04341-7
Guy S, Al Askari M. Haemorrhagic gastritis following Gastrografin administration for adhesive small bowel obstruction: a case report of a rare outcome. Int J Surg Case Rep 2017; 33(1): 51-54. https://doi.org/10.1016/j.ijscr.2017.02.030
Heng S, Hardy J, Good P. A retrospective audit on usage of Diatrizoate Meglumine (Gastrografin®) for intestinal obstruction or constipation in patients with advanced neoplasms. Palliat Med 2018; 32(1): 294-298.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Muhammad Zubair, Syed Muhammad Noman, Ammad ud Din Nasir, Arsalan Sharif Malik, Faheem Ullah Naz, Amna Ramzan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
